This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration. Need a new registration confirmation email? Click here
August 1, 2012 8:00 am ET
Susie Lisa - Senior Director of Investor Relations and Corporate Development
Mike Minogue - Chairman, President and Chief Executive Officer
Bob Bowen - Vice President and Chief Financial Officer
Brooks West - Piper Jaffray
Greg Simpson - Wunderlich Securities
Anthony Petrone - Jefferies
Steve Beuchaw - Morgan Stanley
Good day, ladies and gentlemen and welcome to the Abiomed first quarter 2013 earnings conference call. At this time, all participants are in a listen-only mode. Later, we will conduct a question-and-answer session, and instructions will be given at that time. [Operator Instructions] As a reminder, today's call is being recorded.
I would now like to turn the conference over to Susie Lisa. Ma'am, you may begin.
Thanks you, good morning everyone and welcome to Abiomed's first quarter fiscal 2013 earnings conference call. I am Susie Lisa, Senior Director of Investor Relations and Corporate Development for Abiomed and I am here with Mike Minogue, Abiomed's Chairman, President and Chief Executive Officer; and Bob Bowen, Vice President and Chief Financial Officer.
The format for today's call will be as follows. First, Mike will discuss strategic highlights from the quarter against the framework of our key operational and strategic objectives for fiscal 2013. Bob will then review the financial results for the quarter and provide an update on guidance for the year. We will then open the call to your questions.
Before turning the call over to Mike, I want to remind you that during the course of today's conference and the question-and-answer session that follows, we may make projections or other forward looking statements that are subject to the Safe Harbor provisions of securities laws regarding future events or the financial performance of the company.